Nuvalent, Inc.
NASDAQ:NUVL
75.87 (USD) • At close April 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 217.774 | 113.243 | 63.731 | 35.559 | 15.403 | 9.746 |
| General & Administrative Expenses
| 62.594 | 36.249 | 22.377 | 10.258 | 1.502 | 0.612 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 62.594 | 36.249 | 22.377 | 10.258 | 1.502 | 0.612 |
| Other Expenses
| 0 | 0 | 4.254 | -0.521 | 2.349 | -1.451 |
| Operating Expenses
| 280.368 | 149.492 | 86.108 | 45.817 | 16.905 | 10.358 |
| Operating Income
| -280.368 | -149.492 | -86.108 | -45.817 | -16.905 | -10.358 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 20.376 | 23.273 | 4.254 | -0.521 | 2.349 | -1.451 |
| Income Before Tax
| -259.992 | -126.219 | -81.854 | -46.338 | -14.556 | -11.809 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.764 | 0 | -8.508 | -0.237 | -0.017 | -0.01 |
| Net Income
| -260.756 | -126.219 | -73.346 | -46.338 | -14.556 | -11.809 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -3.93 | -2.17 | -1.48 | -0.96 | -0.3 | -0.24 |
| EPS Diluted
| -3.93 | -2.17 | -1.48 | -0.96 | -0.3 | -0.24 |
| EBITDA
| -280.368 | -126.219 | -86.108 | -45.817 | 2.349 | -1.451 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |